Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.21 by 33.33 percent. This is a 75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $6.978 billion which missed the analyst consensus estimate of $7.050 billion by 1.02 percent. This is a 0.54 percent decrease over sales of $7.016 billion the same period last year.